Age increases leucine enkephalin hydrolysis in human plasma

Gerontology

Volumn 45, Issue 1, 1999, Pages 10-16

  Bongiorno, Lucilla ^a   Marzano, Marina ^a   Marini, Mario ^a   Roda, L Giorgio ^a   Urbani, Alessandra ^a   Spagnoli, Giulio ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Univ Studi di Roma Tor Vergata ^*

Author keywords

Enzyme inhibitors; Hydrolysis; Immune system; Opioid peptides

Indexed keywords

ENZYME INHIBITOR; LEUCINE ENKEPHALIN; NEUROPEPTIDE; OPIATE PEPTIDE;

AGED; AGING; ARTICLE; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GROUPS BY AGE; HUMAN; HYDROLYSIS; HYPOTHESIS; IMMUNE SYSTEM; KINETICS; PLASMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; STATISTICAL ANALYSIS;

ADULT; AGED; AGING; ENDOPEPTIDASES; ENKEPHALIN, LEUCINE; FEMALE; HUMANS; HYDROLYSIS; KINETICS; MALE; MODELS, BIOLOGICAL; NEUROIMMUNOMODULATION; SIGNAL TRANSDUCTION;

EID: 0032961295     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022049     Document Type: Article

References (29)

1. Miller RA: Aging and immune function. Int Rev Cytol 1991;124:187-215.
2. Powers DC, Belshe RB: Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody response elicited by inactivated influenza virus vaccine. J Infect Dis 1993;167:584-592.
3. Licastro F, Morini MC, Chiricolo M, Belletti D. Malpassi P, Parente R, Carpené E, Conte R: Functional assessment of cellular non-specific and specific immunity in selected healthy elderly. Arch Gerontol Geriatr 1992;3:219-228.
4. + (CD 16) large granular lymphocytes and decreased NK activity during human ageing. Clin Exp Immunol 1987;68:340-347.
5. Lerner A, Yamada T, Miller RA: Pgp-1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A. Eur J Immunol 1989;19:977-982.
6. + channels in Alzheimer's disease. J Psychiatr Res 1996;30:21-227.
7. Fülöp T Jr, Leblanc C, Lacombe G, Dupuis G: Cellular distribution of protein kinase C isoenzimes in CD3-mediated stimulation of human T lymphocytes with aging. FEBS Lett 1995; 375:69-74.
8. Gillis S, Kozak R, Durante M, Weksler ME: Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest 1981;67:937-942.
9. Hobbs MV, Weigle WO, Ernst DN: Interleukin-10 production by splenic CD4+ cells and cell subsets from young and old mice. Cell lmmunol 1994;154:264-272.
10. Klinman NR, Thorbecke GJ: Aging associated changes in the generation and development of B cell memory. Int Rev Immunol 1995;12:5-12.
11. Yang X, Streda J, Cerny J: Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J Exp Med 1996;183: 959-970.
12. Cha CI, Lee YI, Lee EY, Park KH: Age-related changes of VIP, NPY and somatostatin-immunoreactive neurons in the cerebral cortex of aged rats. Brain Res 1997;753:235-244.
13. Thai L, Hong JS, Wiley RG, Gallagher M: The regulation of hippocampal dynorphin by neural/neuroendocrine pathways: Model for effects of aging on an opioid peptide system. Neuroscience 1996;70:661-671.
14. Plotnikoff NP, Miller GC: Enkephalins as immunomodulators. Int J Immunopharmacol 1983;5:437-441.
15. Roda LG, Bongiorno L, Trani E, Urbani A, Marini M: Positive and negative immunomodulation by opioid peptides. Int J Immunopharmacol 1996;18:1-16.
16. Plotnikoff NP, Faith RE, Murgo AJ, Herberman RB, Good RA: Methionine enkephalin: A new cytokine. Human studies. Clin Immunol Immunopathol 1997;82:93-101.
17. Buzzetti R, McLoughlin L, Lavender PM, Clark AJL, Rees LH: Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 1989;83:733-737.
18. Bowes MA, Kenny AJ: An immunohistochemical study of endopeptidase-24.11 and amino-peptidase N in lymphoid tissues. Immunology 1987;60:247-253.
19. Marini M, Urbani A, Bongiorno L, Roda LG: Hydrolysis and association of leucine enkephalin to lymphomic and erythroleukaemic cell lines. III. Soluble enzymes. Int J Immunopharmacol 1992;14:995-1002.
20. Bolacchi F, Marini M, Urbani A, Roda LG: Enzymes and inhibitors of leu-enkephalin metabolism in human plasma. Neurochem Res 1995;20:991-999.
21. Aronin N, Wiesen M, Liotta AS, Schlussler GC, Krieger DT: Comparative metabolic clearance rates of β-endorphin and β-lipotropin in humans. Life Sci 1981;29:1265-1269.
22. Drapeau G, Chow A, Ward PE: Metabolism of bradikinin analogs by angiotensin I converting enzyme and carboxypeptidase N. Peptides 1991;12:631-638.
23. Saksida LM, Galea LAM, Kavaliers M: Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis. Peptides 1993;14:763-765.
24. Daugé V, Mauborgne A, Casselin F, Fournié-Zalusky M-C, Roques B-P: The dual peptidase inhibitor RB101 induces a long-lasting increase in the extracellular level of met-enkephalin-like material in the nucleus accumbens of freely moving rats. J Neurochem 1996;67:1301-1308.
25. Young EA, Houghten RA, Akil H: Degradation of [3H] β-endorphin in rat plasma is increased with chronic stress. Eur J Pharmacol 1989;16: 229-236.
26. Marini M, Urbani A, Trani E, Bongiorno L, Roda LG: Interindividual variability of enkephalin-degrading enzymes in human plasma. Peptides 1997;18:741-748.
27. Bolacchi F, Marini M, Urbani A, Gilardi E, Roda LG: Role of enzymes and inhibitors in leu-enkephalin metabolism in Oryctolagus and human plasma. Neurochem Res 1996;21:881-890.
28. Nieber K, Baumgarten CR, Rathsak R, Furkert L, Oehme P, Kunkel G: Substance P and beta-endorphin-like immunoreactivity in lavage fluid of subjects with and without allergic asthma. J Allergy Clin Immunol 1992;90:646-654.
29. Laudenslager ML, Ryan SM, Drugan RC, Hayson RL, Mayer SF: Coping and immunosuppression: Inescapable but not escapable shock supresses lymphocyte proliferation. Science 1983;221:568-570.